{"id":"polihexanide-2","safety":{"commonSideEffects":[{"rate":null,"effect":"Local irritation or burning sensation"},{"rate":null,"effect":"Allergic contact dermatitis"},{"rate":null,"effect":"Tissue toxicity at high concentrations"}]},"_chembl":{"chemblId":"CHEMBL2106939","moleculeType":"Small molecule","molecularWeight":"185.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Polihexanide is a biguanide-based antiseptic that works by binding to negatively charged microbial cell membranes, causing disruption and leakage of cellular contents. It exhibits rapid bactericidal and fungicidal activity against a wide range of gram-positive and gram-negative bacteria, as well as fungi and some viruses. The 2% formulation is typically used for wound irrigation and antiseptic applications.","oneSentence":"Polihexanide is a broad-spectrum antimicrobial agent that disrupts bacterial and fungal cell membranes through electrostatic interactions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:29:28.901Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Wound irrigation and antisepsis"},{"name":"Burn wound management"},{"name":"Chronic wound care"}]},"trialDetails":[{"nctId":"NCT07391748","phase":"EARLY_PHASE1","title":"Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers","status":"NOT_YET_RECRUITING","sponsor":"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","startDate":"2026-01-30","conditions":"Pressure Ulcers, Pressure Ulcers Stage III, Pressure Ulcer Prevention","enrollment":140},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT05775614","phase":"NA","title":"UROtainer for Bladder Catheter Maintenance, Infection Prevention and Quality of Life","status":"ENROLLING_BY_INVITATION","sponsor":"Odense University Hospital","startDate":"2022-05-01","conditions":"Catheter Blockage","enrollment":70},{"nctId":"NCT06297967","phase":"PHASE3","title":"Acetic Acid 2% Solution for Skin Ulcers","status":"RECRUITING","sponsor":"Consorci Sanitari de l'Alt Penedès i Garraf","startDate":"2025-04-27","conditions":"Ulcer, Skin","enrollment":104},{"nctId":"NCT06309368","phase":"PHASE4","title":"Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure","status":"RECRUITING","sponsor":"University of Nevada, Las Vegas","startDate":"2024-03-14","conditions":"Surgical Site Infection, Wound Surgical, Colorectal Disorders","enrollment":84},{"nctId":"NCT06618612","phase":"NA","title":"A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers","status":"RECRUITING","sponsor":"Organogenesis","startDate":"2024-08-19","conditions":"Diabetic Foot Ulcer","enrollment":170},{"nctId":"NCT06718777","phase":"NA","title":"Effect of Two Different Solutions on Wound Healing in Pressure Injury","status":"COMPLETED","sponsor":"Mensure Turan","startDate":"2023-08-01","conditions":"Pressure Injuries, Wound Care, Wound Cleansing","enrollment":63},{"nctId":"NCT05132179","phase":"NA","title":"Treating Diabetic Foot Ulcers, Comparing Two Topical Antimicrobial Agents, Dakin´s and Prontosan","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2022-02-01","conditions":"Diabetic Foot Ulcer","enrollment":202},{"nctId":"NCT04188574","phase":"PHASE2","title":"A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail","status":"COMPLETED","sponsor":"Blueberry Therapeutics","startDate":"2021-03-22","conditions":"Distal Subungual Onychomycosis, Fungal Infection, Fungus, Nail","enrollment":111},{"nctId":"NCT02652169","phase":"NA","title":"PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2014-06","conditions":"Chronic Skin Ulcer","enrollment":120},{"nctId":"NCT02537730","phase":"NA","title":"BIOCLEAN MPS (Multi-Purpose Solution) VII in Combination With Biofinity Lens: A Two Week Crossover Study","status":"COMPLETED","sponsor":"CooperVision, Inc.","startDate":"2015-09","conditions":"Myopia","enrollment":33},{"nctId":"NCT02375178","phase":"NA","title":"Antimicrobial Activity of Two Mouthwashes","status":"COMPLETED","sponsor":"Universidade do Vale do Sapucai","startDate":"2014-08","conditions":"Periimplantitis, Dental Plaque, Periodontal Diseases","enrollment":30},{"nctId":"NCT02643680","phase":"PHASE2","title":"Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2015-11","conditions":"Wound, Disorder of Skin Donor Site","enrollment":32},{"nctId":"NCT02394821","phase":"PHASE3","title":"Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2013-09","conditions":"Neoplasm, Wounds and Injuries","enrollment":24},{"nctId":"NCT00618787","phase":"PHASE2","title":"Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing","status":"COMPLETED","sponsor":"Tyco Healthcare Group","startDate":"2008-02","conditions":"Wounds","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":224,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Polihexanide 2%","genericName":"Polihexanide 2%","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Polihexanide is a broad-spectrum antimicrobial agent that disrupts bacterial and fungal cell membranes through electrostatic interactions. Used for Wound irrigation and antisepsis, Burn wound management, Chronic wound care.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}